CD274 and squamous cell lung carcinoma: Some studies suggest the greater efficacy of immunotherapy in patients with higher PD-L1 expression [9,22,24,25], but in the CheckMate-017 study of patients with squamous cell lung cancer, the same response to treatment was observed regardless of PD-L1 expression [26].